Page last updated: 2024-11-02

moxonidine and Arrhythmias, Cardiac

moxonidine has been researched along with Arrhythmias, Cardiac in 7 studies

moxonidine: structure given in first source

Arrhythmias, Cardiac: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.

Research Excerpts

ExcerptRelevanceReference
"We previously reported that imidazoline receptors in the central nervous system are involved in modulation of halothane-epinephrine arrhythmias."7.73Identification of the central imidazoline receptor subtype involved in modulation of halothane-epinephrine arrhythmias in rats. ( Hayashi, Y; Itoh, I; Iwasaki, M; Kagawa, K; Kamibayashi, T; Mashimo, T; Takada, K; Yamatodani, A, 2005)
" Due to the important role of the sympathetic nervous system in the genesis of neurogenic cardiac arrhythmias, we investigated the antiarrhythmic effects of moxonidine and compared them to those of propranolol in an experimental model of neurogenic arrhythmias."7.70Protective effects of I(1)-antihypertensive agent moxonidine against neurogenic cardiac arrhythmias in halothane-anesthetized rabbits. ( Christen, MO; Poisson, D; Sannajust, F, 2000)
"The aim of the present study was to investigate the influence of moxonidine, a representative of I1-imidazoline-receptor agonist, on arrhythmias induced by myocardial ischemia or reperfusion."7.69Effect of moxonidine on arrhythmias induced by coronary artery occlusion and reperfusion. ( Leprán, I; Papp, JG, 1994)
" In the first experiment the threshold dose of ouabain needed to induce ventricular arrhythmia and asystole was determined in guinea pigs, and the influence of moxonidine was tested."7.69Antiarrhythmic effect of the selective I1-imidazoline receptor modulator moxonidine on ouabain-induced cardiac arrhythmia in guinea pigs. ( Mest, HJ; Raap, A; Thomsen, P, 1995)
"We previously reported that imidazoline receptors in the central nervous system are involved in modulation of halothane-epinephrine arrhythmias."3.73Identification of the central imidazoline receptor subtype involved in modulation of halothane-epinephrine arrhythmias in rats. ( Hayashi, Y; Itoh, I; Iwasaki, M; Kagawa, K; Kamibayashi, T; Mashimo, T; Takada, K; Yamatodani, A, 2005)
" Due to the important role of the sympathetic nervous system in the genesis of neurogenic cardiac arrhythmias, we investigated the antiarrhythmic effects of moxonidine and compared them to those of propranolol in an experimental model of neurogenic arrhythmias."3.70Protective effects of I(1)-antihypertensive agent moxonidine against neurogenic cardiac arrhythmias in halothane-anesthetized rabbits. ( Christen, MO; Poisson, D; Sannajust, F, 2000)
"The aim of the present study was to investigate the influence of moxonidine, a representative of I1-imidazoline-receptor agonist, on arrhythmias induced by myocardial ischemia or reperfusion."3.69Effect of moxonidine on arrhythmias induced by coronary artery occlusion and reperfusion. ( Leprán, I; Papp, JG, 1994)
" In the first experiment the threshold dose of ouabain needed to induce ventricular arrhythmia and asystole was determined in guinea pigs, and the influence of moxonidine was tested."3.69Antiarrhythmic effect of the selective I1-imidazoline receptor modulator moxonidine on ouabain-induced cardiac arrhythmia in guinea pigs. ( Mest, HJ; Raap, A; Thomsen, P, 1995)
"Moxonidine has been shown to be antiarrhythmic during ischaemia in vivo."1.30Facilitation of spontaneous defibrillation by moxonidine during regional ischaemia in an isolated working rabbit heart model. ( Cobbe, SM; Hicks, MN; Kane, KA; Wolk, R, 1999)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (71.43)18.2507
2000's2 (28.57)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kagawa, K1
Hayashi, Y1
Itoh, I1
Iwasaki, M1
Takada, K1
Kamibayashi, T1
Yamatodani, A1
Mashimo, T1
Leprán, I1
Papp, JG1
Mest, HJ1
Thomsen, P1
Raap, A1
Lada, W1
Wolk, R1
Kane, KA1
Cobbe, SM1
Hicks, MN1
Bousquet, P1
Feldman, J1
Poisson, D1
Christen, MO1
Sannajust, F1

Reviews

2 reviews available for moxonidine and Arrhythmias, Cardiac

ArticleYear
[Imidazoline receptors and use of drug blocking receptors I1].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 1996, Volume: 1, Issue:2

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Antihypertensive Agents; Arrhythmias, Cardi

1996
Drugs acting on imidazoline receptors: a review of their pharmacology, their use in blood pressure control and their potential interest in cardioprotection.
    Drugs, 1999, Volume: 58, Issue:5

    Topics: Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Heart Failure; Hum

1999

Other Studies

5 other studies available for moxonidine and Arrhythmias, Cardiac

ArticleYear
Identification of the central imidazoline receptor subtype involved in modulation of halothane-epinephrine arrhythmias in rats.
    Anesthesia and analgesia, 2005, Volume: 101, Issue:6

    Topics: Animals; Arrhythmias, Cardiac; Benzofurans; Blood Pressure; Dose-Response Relationship, Drug; Epinep

2005
Effect of moxonidine on arrhythmias induced by coronary artery occlusion and reperfusion.
    Journal of cardiovascular pharmacology, 1994, Volume: 24 Suppl 1

    Topics: Analysis of Variance; Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Coronary Vessels; Dise

1994
Antiarrhythmic effect of the selective I1-imidazoline receptor modulator moxonidine on ouabain-induced cardiac arrhythmia in guinea pigs.
    Annals of the New York Academy of Sciences, 1995, Jul-12, Volume: 763

    Topics: Aconitine; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Animals

1995
Facilitation of spontaneous defibrillation by moxonidine during regional ischaemia in an isolated working rabbit heart model.
    European journal of pharmacology, 1999, Feb-12, Volume: 367, Issue:1

    Topics: Action Potentials; Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Disease Models, Animal; E

1999
Protective effects of I(1)-antihypertensive agent moxonidine against neurogenic cardiac arrhythmias in halothane-anesthetized rabbits.
    The Journal of pharmacology and experimental therapeutics, 2000, Volume: 293, Issue:3

    Topics: Anesthesia; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Arrhythmias, Cardiac; Blood Pr

2000